Author name: Jeffrey Lindsay

The Anti-Patent Revolution in the United States

Many intellectual property practitioners worldwide are scratching their heads over what is happening to IP in the United States. There’s a revolution underway that over the past few years seems to have steadily eroded the value of patents and any semblance of predictability and order in the law. Patents can still be valuable, if you …

The Anti-Patent Revolution in the United States Read More »

Simple Steps Can Dramatically Increase Participation in Innovation

At the IP Business Congress Asia 2014 (IPBC Asia 2014), a collection of IP experts from around the world are here in Shanghai, China sharing best practices and advice to help fellow IP workers. Yesterday during a panel discussing ways to build a world-class in-house IP team, a comment from the audience provided a valuable …

Simple Steps Can Dramatically Increase Participation in Innovation Read More »

Unpatentable “Abstract” Claims in US Patent Law: How To Know It When You See It, Thanks to Abstract Art

The US Supreme Court recently ruled that “abstract” concepts are not eligible for patents. The 2014 case, Alice Corporation Pty. Ltd. v. CLS Bank Intl. or more simply Alice, is said by some to mean the death of thousands of patents if not entire industries. Critics such as Gene Quinn say it is unworkable, vague and …

Unpatentable “Abstract” Claims in US Patent Law: How To Know It When You See It, Thanks to Abstract Art Read More »

Monopolies vs. Health Care Innovation: What Happens When Incumbents Decide Who Gets to Compete?

Monopolies can innovate, just like elephants can play tennis. The results usually just aren’t very elegant or successful. Competition, on the other hand, is famous for driving innovation. Even in state-owned monopolies, like NASA’s initial monopoly on space exploration in the US, it was competition between nations during the rush to outer space and then …

Monopolies vs. Health Care Innovation: What Happens When Incumbents Decide Who Gets to Compete? Read More »

David and Googleliath (or VSL vs. Google): A Small Company Fighting a Giant Reminds Us Why Software Patents Matter

A small start-up company fighting one of the great giants of all time: it’s a classic story of David vs. Goliath, or in this case, David vs. Googleliath (a.k.a. VSL vs. Google). Many small companies have claimed that Google misappropriated trade secrets or other IP, but rarely has Google graciously (and accidentally) cooperated in providing …

David and Googleliath (or VSL vs. Google): A Small Company Fighting a Giant Reminds Us Why Software Patents Matter Read More »

Crazy Over Innovation at Uber

At the Marcus Evans Innovate 2014 Conference in Shanghai today, I met Rosalie Wu, the head of marketing in China for the rapidly growing startup, Uber. Rosalie was Uber’s first hire in China and exemplifies the energetic, entrepreneurial spirit that is driving Uber to global success. She spoke about the development of Uber’s innovative business …

Crazy Over Innovation at Uber Read More »

Alice in Blunderland: The Supreme Court’s Alice Decision Fails to Grasp the Physical Reality of Information

The recent Alice decision from the Supreme Court threatens patents for many innovators working with computers, software, information, and knowledge–in short, the heart of the modern Knowledge Economy. By waving around the undefined word “abstract”–a word that the Court expressly refused to define–they have ruled that a major part of the economy is simply not …

Alice in Blunderland: The Supreme Court’s Alice Decision Fails to Grasp the Physical Reality of Information Read More »

Another Surprise from China: The Tralin/Tranlin IP-Backed Financing Results in Jobs and Green Technology for the US

In a previous post here, I reported a huge loan to a Chinese paper company backed by its mostly Chinese IP as collateral. The 8 billion RMB obtained by China’s Tralin Paper (Quanlin Paper in Chinese, though they use www.tralin.com for their website), one of the biggest IP-backed loans in the world, not only shows …

Another Surprise from China: The Tralin/Tranlin IP-Backed Financing Results in Jobs and Green Technology for the US Read More »

Another Innovation Knifing: Cutting “Natural Products” Out of the Scope of Patentable Subject Matter

One of the important new antibiotics discovered and developed by pharmaceutical companies in the past few years is Rifampicin and its relative Rifamycin. These potent antibiotics remain key tools in fighting off serious infection. Their story begins with a soil sample taken from a pine forest on the French Riviera in 1957 that was then studied …

Another Innovation Knifing: Cutting “Natural Products” Out of the Scope of Patentable Subject Matter Read More »

Scroll to Top